Researchers at the Montreal Behavioural Medicine Centre (MBMC) say people with noncommunicable diseases (NCDs) such as heart disease, cancer, diabetes, or chronic lung ailments were disproportionately impacted by the COVID-19 pandemic.
Models used by scientists to predict how epidemics will spread have a major flaw since they do not take into account the structure of the networks underlying transmission.
Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.
In a real-world setting, analysis showed that risk of infection and severe illness was significantly lower for those who were vaccinated against COVID-19, and cardiac conditions did not increase
New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.
• Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of COVID-19 in tests with hamsters
As the new year kicks into full swing, so has a trio of respiratory viruses, creating a so-called tripledemic.
A collaborative study led by Dr. Estefanía Nova-Lamperti of the Universidad de Concepción, Dr. Gonzalo Labarca of Harvard University, and Mauricio Hernández, of MELISA Institute, and which included the participation of researchers from leading academic institutions, sought to identify the sequelae associated with long-term pulmonary dysfunction (L-PDD) in patients with COVID-19.
A new study shows COVID-19 is not linked to long-term loss of kidney function, despite many patients hospitalized with the -19 virus who experienced acute kidney injury.
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS.
Novel insights from the pandemic may be propelling the field of immunology into a new golden age.
Study examines the impact of flu, RSV and COVID-19 hitting pediatric emergency departments
Quality of life for people with dementia living in residential and nursing home care substantially improved after staff took part in a digital training programme that was specially adapted to Covid-19 restrictions. The training also led to a significant drop in the prescription of potentially harmful sedative medications to residents.
New research has revealed that Rembrandt impregnated the canvas for his famous 1642 militia painting ‘The Night Watch’ with a lead-containing substance even before applying the first ground layer.
A protective mineral coating identified by University of Wisconsin–Madison biomedical engineering researchers could allow powerful messenger RNA therapeutics like COVID-19 vaccines to be stored at room temperature, making them more accessible to lower-resourced communities across the world.In a new paper in the journal Acta Biomaterialia, Professor William Murphy and collaborators in his lab detail how using an optimized mineral coating composition can maintain mRNA activity for up to six months at room temperature.
A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.
New research from Cedars-Sinai’s Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the drug as a preventive measure against the disease.
New research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System comparing the viruses that cause the flu and COVID-19 shows that people hospitalized with seasonal influenza also can suffer long-term, negative health effects, especially involving their lungs and airways. The study also found that in the 18 months after infection, patients hospitalized for either COVID-19 or seasonal influenza faced an increased risk of death, hospital readmission, and other health problems.
Findings published in the journal Nature by physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) and colleagues suggest that it may be possible to improve protection against COVID-19 by delivering the vaccine directly to the respiratory tract— the primary site of entry in SARS-CoV-2 infection.
SARS-CoV-2 persists in the respiratory tract, notably in patients with underlying co-morbidities including liver disease.
With virus cases rising and the holidays nigh, three expert from University of Michigan Health give their top 12 tips for avoiding or reducing the impact of COVID-19, flu, RSV, pneumonia and whooping cough in adults and kids.
Individuals infected with COVID-19 are also at an increased risk of suffering from heart rhythm disturbances, such as atrial fibrillation. This is shown in a new study at Umeå University, Sweden, which is one of the largest studies of its kind in the world.
College students reporting increased mental distress during the pandemic also reported greater quantity and frequency of alcohol use, and distress was linked to certain pandemic-related factors which differed by race.
The new study is among the first to quantify unmet demand for the vaccine — people who would be willing to be vaccinated if they had access.
Lung airway cells of people with alcohol use disorder developed “enhanced inflammation” three days after being infected with SARS-CoV-2, the virus that causes COVID-19, according to a new study from Emory University School of Medicine in Atlanta and the University of Georgia.
Imagine the ability to quickly and accurately diagnose if you are infected with influenza, respiratory syncytial virus (RSV) or COVID-19 with one breath in less than a minute.
Researchers at Linköping University, Sweden, have examined the brains of 16 patients previously hospitalised for COVID-19 with persisting symptoms. They have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people. Their findings, published in the journal Brain Communications, can bring insights into the underlying mechanisms of persisting neurological problems after COVID-19.
Living through a historic pandemic while handling the stress of the first year of college sent one-third of students in a new study into clinical depression. That’s double the percentage seen in previous years of the same study.
What should you do if your child has a fever? When should you call the doctor? Christopher Tolcher, MD, FAAP, a pediatrician with Agoura-West Valley Pediatrics—part of the CHLA Health Network—shares the facts on fever and what parents need to know.
Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to target CD19, show a 100 percent complete response (CR) rate at the higher dose levels studied in the trial, according to researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center.
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut Pasteur specialized in HIV, in collaboration with a French public research institute, the Alternative Energies and Atomic Energy Commission (CEA), conducted a study on lung cells in an animal model.
According to new predictions by La Jolla Institute for Immunology (LJI) researchers, if the new SARS-CoV-2 Pirola variant wants to evade T cells, it isn't doing a very good job.
A special report published today in the Association for Diagnostics & Laboratory Medicine’s (ADLM’s, formerly AACC’s) The Journal of Applied Laboratory Medicine describes the design, operations, and methodology of the COVID Immunity Study, a large-scale scientific study by ADLM that took place in September 2021.
Many couples were unprepared for the impact COVID-19 could have on romantic relationships, but those who were able to adjust by creating new routines and adopting a positive attitude were more likely to weather the storm, according to a study by Rutgers researchers.
Although adolescents are less susceptible to illness from COVID-19 than older people, there is evidence suggesting that pandemic lockdowns limited their ability to thrive.
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent ‘off-target’ immune responses to enable the safer design of future mRNA therapeutics.
Francesca Torriani, MD, infectious disease specialist at UC San Diego Health available to discuss importance of vaccination against influenza.
The federal government has expanded the Home Test to Treat program, an entirely virtual community health program that offers free COVID-19 health services: at-home rapid tests, telehealth sessions and at-home treatments, to eligible participants nationwide.
In an effort to improve the health of Tribal communities and Indigenous people, the National Institutes of Health (NIH) has awarded $9 million in funding for Native scientists at Arizona State University and elsewhere to create the first Indigenous-led Tribal Data Repository.
Researchers at Flinders University and the University of South Australia examined whether attending an event virtually or in-person makes a difference to loneliness and social connectedness.
Bahareh Behkam and collaborators have received a $2 million grant from the National Science Foundation (NSF) to continue their fight against airborne pathogens. An associate professor of mechanical engineering, Behkam and her team will use the funding to further develop engineered living systems for indoor air monitoring. Currently, there is a lack of sensitive, specific, affordable, and easy-to-use airborne pathogen monitoring technology and an overwhelming need for innovative approaches to address this challenge.
New research by the University of Bristol has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration. The findings could strengthen the arsenal of antiviral drugs available to combat current and future coronavirus outbreaks.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
